BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 627883)

  • 1. Methadone dose, plasma level, and cross-tolerance to heroin in man.
    Volavka J; Verebey K; Resnick R; Mulé S
    J Nerv Ment Dis; 1978 Feb; 166(2):104-9. PubMed ID: 627883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pupillary response to methadone challenge in heroin users.
    Higgins ST; Stitzer ML; McCaul ME; Bigelow GE; Liebson IA
    Clin Pharmacol Ther; 1985 Apr; 37(4):460-3. PubMed ID: 3979006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pupil responses to intravenous heroin (diamorphine) in dependent and non-dependent humans.
    Tress KH; El-Sobky AA
    Br J Clin Pharmacol; 1979 Feb; 7(2):213-7. PubMed ID: 760755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone dose and heroin use during maintenance treatment.
    Caplehorn JR; Bell J; Kleinbaum DG; Gebski VJ
    Addiction; 1993 Jan; 88(1):119-24. PubMed ID: 8448501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program.
    Torrens M; Castillo C; San L; del Moral E; González ML; de la Torre R
    Drug Alcohol Depend; 1998 Nov; 52(3):193-200. PubMed ID: 9839145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone dose assessment in heroin addiction.
    Aylett P
    Int J Addict; 1982 Dec; 17(8):1329-36. PubMed ID: 7174170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pupillary correlates of methadone treatment in heroin postaddicts.
    Campbell KB; Mandelzys N; Mills GK
    Int J Addict; 1979 Jul; 14(5):627-38. PubMed ID: 478708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequate plasma concentrations in some high-dose methadone maintenance patients.
    Tennant FS
    Am J Psychiatry; 1987 Oct; 144(10):1349-50. PubMed ID: 3661772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
    Tennant FS; Rawson RA; Cohen A; Tarver A; Clabough D
    NIDA Res Monogr; 1984 Mar; 49():262-8. PubMed ID: 6434970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
    Tennant FS; Rawson RA; Cohen A; Tarver A; Clabough D
    Subst Alcohol Actions Misuse; 1983; 4(5):369-74. PubMed ID: 6670059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment.
    Hiltunen AJ; Beck O; Hjemdahl P; Liljeberg P; Almström U; Brodin K; von Wachenfeldt J; Borg S
    Psychopharmacology (Berl); 1999 Apr; 143(4):385-93. PubMed ID: 10367556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
    Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
    Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravenously administered methadone, morphine and heroin.
    Jasinski DR; Preston KL
    Drug Alcohol Depend; 1986 Jul; 17(4):301-10. PubMed ID: 3757766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.
    Borg L; Ho A; Wells A; Joseph H; Appel P; Moody D; Kreek MJ
    J Addict Dis; 2002; 21(3):13-22. PubMed ID: 12094997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone maintenance: optimizing dosage by estimating plasma level.
    Dole VP
    J Addict Dis; 1994; 13(1):1-4. PubMed ID: 8018735
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methadone dose, treatment duration and heroin use in drug-assisted rehabilitation].
    Kornør H; Waal H
    Tidsskr Nor Laegeforen; 2004 Feb; 124(3):332-4. PubMed ID: 14963504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a single 50% extra dose of methadone on heroin craving and mood in lower- versus higher-dose methadone patients.
    Strasser J; Wiesbeck GA; Meier N; Stohler R; Dürsteler-Macfarland KM
    J Clin Psychopharmacol; 2010 Aug; 30(4):450-4. PubMed ID: 20571436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone dose and urine morphine.
    Maddux JF; Esquivel M; Vogtsberger KN; Desmond DP
    J Subst Abuse Treat; 1991; 8(4):195-201. PubMed ID: 1664864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levomethadyl acetate. Prolonged duration of opioid effects, including cross tolerance to heroin, in man.
    Levine R; Zaks A; Fink M; Freedman AM
    JAMA; 1973 Oct; 226(3):316-8. PubMed ID: 4740931
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.